0000950170-23-060286.txt : 20231107
0000950170-23-060286.hdr.sgml : 20231107
20231107161833
ACCESSION NUMBER: 0000950170-23-060286
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231031
FILED AS OF DATE: 20231107
DATE AS OF CHANGE: 20231107
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cafico Trust Co Ltd
CENTRAL INDEX KEY: 0001685917
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41837
FILM NUMBER: 231384209
BUSINESS ADDRESS:
STREET 1: PALMERSTOWN HOUSE, FENIAN STREET
CITY: DUBLIN
STATE: L2
ZIP: DUBLIN 2
BUSINESS PHONE: 0035319058020
MAIL ADDRESS:
STREET 1: PALMERSTOWN HOUSE, FENIAN STREET
CITY: DUBLIN
STATE: L2
ZIP: DUBLIN 2
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mural Oncology plc
CENTRAL INDEX KEY: 0001971543
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 EARLSFORT TERRACE
CITY: DUBLIN 2
STATE: L2
ZIP: D02 T380
BUSINESS PHONE: 353 1 905 8020
MAIL ADDRESS:
STREET 1: 10 EARLSFORT TERRACE
CITY: DUBLIN 2
STATE: L2
ZIP: D02 T380
FORMER COMPANY:
FORMER CONFORMED NAME: Mural Oncology Ltd
DATE OF NAME CHANGE: 20230403
FORMER COMPANY:
FORMER CONFORMED NAME: Pistachiovale Ltd
DATE OF NAME CHANGE: 20230329
3
1
ownership.xml
3
X0206
3
2023-10-31
0
0001971543
Mural Oncology plc
MURA
0001685917
Cafico Trust Co Ltd
PALMERSTOWN HOUSE, FENIAN STREET
DUBLIN
L2
DUBLIN 2
IRELAND
false
false
true
false
Ordinary Shares, nominal value $1.00 per share
2
D
Euro Deferred Shares, nominal value 1.00 Euro per share
25000
D
Preferred Share, nominal value $0.01 per share
1
D
The ordinary shares of Mural Oncology plc ("Mural"), nominal value $1.00 per share, beneficially owned by Cafico Trust Company Limited, constitute 100% of the ordinary shares of Mural. As of the date of this report, Alkermes plc ("Alkermes") has announced its intention to separate its oncology business from the rest of Alkermes by means of a declaration of a dividend in specie, to be effected by the transfer of the oncology business from Alkermes to Mural and the issuance by Mural of ordinary shares to Alkermes shareholders.
In connection with the separation of the oncology business, Cafico Trust Company Limited also owns (i) 25,000 Euro deferred shares, nominal value 1.00 Euro per share, and (ii) one preferred share, nominal value $0.01, of Mural.
/s/ Mairead Lyons
2023-11-07